| Field | Row 1 |
|---|---|
| adsh | 0001641172-25-010547 |
| cik | 1763950 |
| name | LANTERN PHARMA INC. |
| sic | 2834 |
| countryba | US |
| stprba | TX |
| cityba | DALLAS |
| zipba | 75201 |
| bas1 | 1920 MCKINNEY AVENUE |
| bas2 | 7TH FLOOR |
| baph | 972-277-1136 |
| countryma | US |
| stprma | TX |
| cityma | DALLAS |
| zipma | 75201 |
| mas1 | 1920 MCKINNEY AVENUE |
| mas2 | 7TH FLOOR |
| countryinc | US |
| stprinc | TX |
| ein | 463973463 |
| former | LANTERN PHARMA |
| changed | 20190108 |
| afs | 4-NON |
| wksi | 0 |
| fye | 1231 |
| form | 10-Q |
| period | 20250331 |
| fy | 2025 |
| fp | Q1 |
| filed | 20250515 |
| accepted | 2025-05-15 08:36:00.0 |
| prevrpt | 0 |
| detail | 1 |
| instance | form10-q_htm.xml |
| nciks | 1 |
| aciks |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| cik | Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings. |
| name | Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date. |
| sic | Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business. |
| countryba | The ISO 3166-1 country of the registrant's business address. |
| stprba | The state or province of the registrant’s business address, if field countryba is US or CA. |
| cityba | The city of the registrant's business address. |
| zipba | The zip code of the registrant’s business address. |
| bas1 | The first line of the street of the registrant’s business address. |
| bas2 | The second line of the street of the registrant’s business address. |
| baph | The phone number of the registrant’s business address. |
| countryma | The ISO 3166-1 country of the registrant's mailing address. |
| stprma | The state or province of the registrant’s mailing address, if field countryma is US or CA. |
| cityma | The city of the registrant's mailing address. |
| zipma | The zip code of the registrant’s mailing address. |
| mas1 | The first line of the street of the registrant’s mailing address. |
| mas2 | The second line of the street of the registrant’s mailing address. |
| countryinc | The ISO 3166-1 country of incorporation for the registrant. |
| stprinc | The state or province of incorporation for the registrant, if countryinc is US or CA. |
| ein | Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States. |
| former | Most recent former name of the registrant, if any. |
| changed | Date of change from the former name, if any. |
| afs | Filer status with the SEC at the time of submission: 1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned. |
| wksi | Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement. |
| fye | Fiscal Year End Date, rounded to nearest month-end. |
| form | The submission type of the registrant’s filing. |
| period | Balance Sheet Date, rounded to nearest month-end. |
| fy | Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8). |
| fp | Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year. |
| filed | The date of the registrant’s filing with the Commission. |
| accepted | The acceptance date and time of the registrant’s filing with the Commission. |
| prevrpt | Previous Report – TRUE indicates that the submission information was subsequently amended. |
| detail | TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount). |
| instance | The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol. |
| nciks | Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing. |
| aciks | Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information. |
| adsh | ddate | tag | value | uom | qtrs | version | segments | coreg | footnote |
|---|---|---|---|---|---|---|---|---|---|
| 0001641172-25-010547 | 20240331 | Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | 134057.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20240331 | Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | 134057.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-010547 | 20240331 | Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
| 0001641172-25-010547 | 20250331 | Assets | 21096335.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20241231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 7511079.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -3579805.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20250331 | Earnings Per Share Basic | -0.4200 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20240331 | Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | -9830.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20250331 | Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 2802.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20240331 | Employee Benefits And Share Based Compensation Noncash | 134057.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20250331 | General And Administrative Expense | 1510077.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20241231 | Liabilities | 4384018.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20250331 | Liabilities | 4319850.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20240331 | Net Cash Provided By Used In Operating Activities | -3068523.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20250331 | Other Comprehensive Income Loss Net Of Tax | -22256.0000 | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001641172-25-010547 | 20250331 | Other Nonoperating Income Expense | 87459.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20250331 | Preferred Stock Shares Authorized | 1000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20250331 | Preferred Stock Shares Outstanding | 0.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20250331 | Property Plant And Equipment Net | 44025.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20231231 | Stockholders Equity | 40907934.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20240331 | Stockholders Equity | 1076.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-010547 | 20241231 | Stockholders Equity | 21187774.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20250331 | Stockholders Equity | 1078.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-010547 | 20240331 | Stock Issued During Period Value New Issues | 54712.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-010547 | 20240331 | Stock Issued During Period Value New Issues | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
| 0001641172-25-010547 | 20250331 | Unrealized Gain Loss On Investments | 151264.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20250331 | Accumulated Other Comprehensive Income Loss Net Of Tax | 131734.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20240331 | Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | |||
| 0001641172-25-010547 | 20250331 | Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | 147750.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20250331 | Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | 147750.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-010547 | 20241231 | Assets | 25571792.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20231231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 21937749.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20250331 | Earnings Per Share Diluted | -0.4200 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20240331 | Foreign Currency Transaction Gain Loss Before Tax | -99338.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20240331 | Increase Decrease In Accounts Payable And Accrued Liabilities | 1270707.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20250331 | Increase Decrease In Operating Lease Liability | -48726.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20250331 | Interest Income Other | 149790.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20241231 | Liabilities Current | 4331175.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20240331 | Net Income Loss | -5440810.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20240331 | Net Income Loss | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | |||
| 0001641172-25-010547 | 20240331 | Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | 65374.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20250331 | Other Comprehensive Income Loss Net Of Tax | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001641172-25-010547 | 20250331 | Other Comprehensive Income Loss Net Of Tax | USD | 1 | us-gaap/2024 | Equity Components= Preferred Stock; | |||
| 0001641172-25-010547 | 20250331 | Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | -8202.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20250331 | Preferred Stock Shares Issued | 0.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20250331 | Proceeds From Sale And Maturity Of Marketable Securities | 8224344.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20240331 | Research And Development Expense | 4250786.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20250331 | Research And Development Expense | 3263955.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20250331 | Shares Outstanding | 10784725.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-010547 | 20250331 | Shares Outstanding | shares | 0 | us-gaap/2024 | Equity Components= Preferred Stock; | |||
| 0001641172-25-010547 | 20231231 | Stockholders Equity | -107460.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001641172-25-010547 | 20231231 | Stockholders Equity | 1072.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-010547 | 20231231 | Stockholders Equity | -55244404.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001641172-25-010547 | 20240331 | Stockholders Equity | 35765217.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20250331 | Stockholders Equity | USD | 0 | us-gaap/2024 | Equity Components= Preferred Stock; | |||
| 0001641172-25-010547 | 20240331 | Weighted Average Number Of Diluted Shares Outstanding | 10742797.0000 | shares | 1 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20241231 | Accumulated Other Comprehensive Income Loss Net Of Tax | 153990.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20241231 | Additional Paid In Capital | 97058323.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -1133477.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20241231 | Common Stock Shares Outstanding | 10784725.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20240331 | Debt Securities Available For Sale Realized Gain Loss | -929.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20250331 | Debt Securities Available For Sale Realized Gain Loss | 10368.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20240331 | Equity Securities Fv Ni Realized Loss | USD | 1 | us-gaap/2024 | ||||
| 0001641172-25-010547 | 20241231 | Marketable Securities Current | 16501984.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20240331 | Net Cash Provided By Used In Financing Activities | 54716.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20250331 | Operating Expenses | 4774032.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20240331 | Operating Income Loss | -5732001.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20240331 | Other Comprehensive Income Loss Net Of Tax | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | |||
| 0001641172-25-010547 | 20250331 | Other Comprehensive Income Loss Net Of Tax | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
| 0001641172-25-010547 | 20250331 | Other Noncash Expense | 47789.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20240331 | Other Nonoperating Income Expense | 90241.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20240331 | Payments To Acquire Property Plant And Equipment | 2217.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20241231 | Preferred Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20241231 | Preferred Stock Shares Issued | 0.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20240331 | Proceeds From Sale And Maturity Of Marketable Securities | 5458333.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20250331 | Retained Earnings Accumulated Deficit | -80562400.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20240331 | Stockholders Equity | 1860.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001641172-25-010547 | 20241231 | Stockholders Equity | USD | 0 | us-gaap/2024 | Equity Components= Preferred Stock; | |||
| 0001641172-25-010547 | 20250331 | Stockholders Equity | 97206073.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-010547 | 20240331 | Stock Issued During Period Shares New Issues | 17481.0000 | shares | 1 | us-gaap/2024 | Equity Components= Warrant; | ||
| 0001641172-25-010547 | 20250331 | Assets Current | 20823376.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20241231 | Accounts Payable And Accrued Liabilities Current | 4140361.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20250331 | Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
| 0001641172-25-010547 | 20241231 | Common Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20241231 | Common Stock Shares Authorized | 25000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20240331 | Earnings Per Share Basic | -0.5100 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20240331 | Interest Income Other | 200950.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20241231 | Liabilities And Stockholders Equity | 25571792.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20240331 | Net Cash Provided By Used In Investing Activities | -556168.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20250331 | Net Cash Provided By Used In Investing Activities | 3239331.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20250331 | Net Income Loss | -4536783.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001641172-25-010547 | 20241231 | Other Assets Noncurrent | 36738.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20240331 | Other Noncash Expense | 41084.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20240331 | Payments To Acquire Marketable Securities | 6012284.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20241231 | Prepaid Expense And Other Assets Current | 1234566.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20240331 | Proceeds From Warrant Exercises | 54716.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20231231 | Shares Outstanding | 10721192.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-010547 | 20241231 | Stockholders Equity | 153990.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001641172-25-010547 | 20250331 | Stockholders Equity | 131734.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001641172-25-010547 | 20240331 | Stock Issued During Period Value New Issues | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | |||
| 0001641172-25-010547 | 20250331 | Weighted Average Number Of Shares Outstanding Basic | 10784725.0000 | shares | 1 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20250331 | Cash And Cash Equivalents At Carrying Value | 6377602.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20241231 | Assets Current | 25247629.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20250331 | Common Stock Shares Authorized | 25000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20250331 | Common Stock Shares Issued | 10784725.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20250331 | Foreign Currency Transaction Gain Loss Before Tax | 17278.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20240331 | General And Administrative Expense | 1481215.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20240331 | Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001641172-25-010547 | 20240331 | Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | USD | 1 | us-gaap/2024 | Equity Components= Preferred Stock; | |||
| 0001641172-25-010547 | 20250331 | Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | |||
| 0001641172-25-010547 | 20250331 | Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001641172-25-010547 | 20250331 | Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | USD | 1 | us-gaap/2024 | Equity Components= Preferred Stock; | |||
| 0001641172-25-010547 | 20241231 | Common Stock Shares Issued | 10784725.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20240331 | Comprehensive Income Net Of Tax | -5331490.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20250331 | Comprehensive Income Net Of Tax | -4559039.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20250331 | Depreciation And Amortization | 4574.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20240331 | Earnings Per Share Diluted | -0.5100 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20250331 | Employee Benefits And Share Based Compensation Noncash | 147750.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20250331 | Equity Securities Fv Ni Realized Loss | 142248.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20240331 | Increase Decrease In Operating Lease Liability | -40887.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20250331 | Marketable Securities Current | 13344049.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20250331 | Net Cash Provided By Used In Financing Activities | USD | 1 | us-gaap/2024 | ||||
| 0001641172-25-010547 | 20240331 | Net Income Loss | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001641172-25-010547 | 20240331 | Net Income Loss | USD | 1 | us-gaap/2024 | Equity Components= Preferred Stock; | |||
| 0001641172-25-010547 | 20250331 | Net Income Loss | -4536783.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20250331 | Net Income Loss | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | |||
| 0001641172-25-010547 | 20250331 | Net Income Loss | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001641172-25-010547 | 20250331 | Net Income Loss | USD | 1 | us-gaap/2024 | Equity Components= Preferred Stock; | |||
| 0001641172-25-010547 | 20241231 | Operating Lease Liability Current | 190814.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20250331 | Operating Lease Liability Current | 161515.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20241231 | Operating Lease Liability Noncurrent | 52843.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20241231 | Operating Lease Right Of Use Asset | 239985.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20250331 | Other Assets Noncurrent | 36738.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20240331 | Other Comprehensive Income Loss Net Of Tax | 109320.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20240331 | Other Comprehensive Income Loss Net Of Tax | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001641172-25-010547 | 20240331 | Other Comprehensive Income Loss Net Of Tax | USD | 1 | us-gaap/2024 | Equity Components= Preferred Stock; | |||
| 0001641172-25-010547 | 20250331 | Payments To Acquire Property Plant And Equipment | 1159.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20250331 | Preferred Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20241231 | Preferred Stock Value | USD | 0 | us-gaap/2024 | ||||
| 0001641172-25-010547 | 20250331 | Prepaid Expense And Other Assets Current | 500000.0000 | USD | 0 | us-gaap/2024 | Type Of Arrangement= License Strategic Alliance And Research Agreements; | ||
| 0001641172-25-010547 | 20250331 | Proceeds From Warrant Exercises | USD | 1 | us-gaap/2024 | ||||
| 0001641172-25-010547 | 20241231 | Property Plant And Equipment Net | 47440.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20231231 | Shares Outstanding | shares | 0 | us-gaap/2024 | Equity Components= Preferred Stock; | |||
| 0001641172-25-010547 | 20240331 | Shares Outstanding | shares | 0 | us-gaap/2024 | Equity Components= Preferred Stock; | |||
| 0001641172-25-010547 | 20231231 | Stockholders Equity | USD | 0 | us-gaap/2024 | Equity Components= Preferred Stock; | |||
| 0001641172-25-010547 | 20240331 | Stockholders Equity | USD | 0 | us-gaap/2024 | Equity Components= Preferred Stock; | |||
| 0001641172-25-010547 | 20250331 | Stockholders Equity | 16776485.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20240331 | Stock Issued During Period Value New Issues | 54716.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20240331 | Unrealized Gain Loss On Investments | 3950.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20240331 | Weighted Average Number Of Shares Outstanding Basic | 10742797.0000 | shares | 1 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20250331 | Additional Paid In Capital | 97206073.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20241231 | Cash And Cash Equivalents At Carrying Value | 7511079.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 18357944.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20250331 | Commitments And Contingencies | USD | 0 | us-gaap/2024 | ||||
| 0001641172-25-010547 | 20250331 | Common Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20250331 | Common Stock Shares Outstanding | 10784725.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20241231 | Common Stock Value | 1078.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20240331 | Depreciation And Amortization | 4061.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20240331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | -901017.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20250331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | -133375.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20250331 | Investment Income Net Amortization Of Discount And Premium | 71373.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20250331 | Liabilities Current | 4286434.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20250331 | Net Cash Provided By Used In Operating Activities | -4375610.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20240331 | Net Income Loss | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | |||
| 0001641172-25-010547 | 20250331 | Operating Lease Liability Noncurrent | 33416.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20250331 | Operating Lease Right Of Use Asset | 192196.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20240331 | Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | 43946.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20250331 | Payments To Acquire Marketable Securities | 4983854.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20250331 | Preferred Stock Value | USD | 0 | us-gaap/2024 | ||||
| 0001641172-25-010547 | 20231231 | Stockholders Equity | 96258726.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-010547 | 20240331 | Stockholders Equity | 96447495.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-010547 | 20241231 | Stockholders Equity | -76025617.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001641172-25-010547 | 20240331 | Stock Issued During Period Value New Issues | USD | 1 | us-gaap/2024 | Equity Components= Preferred Stock; | |||
| 0001641172-25-010547 | 20250331 | Weighted Average Number Of Diluted Shares Outstanding | 10784725.0000 | shares | 1 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20250331 | Increase Decrease In Accounts Payable And Accrued Liabilities | -15554.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20250331 | Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -14054.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20240331 | Other Comprehensive Income Loss Net Of Tax | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
| 0001641172-25-010547 | 20250331 | Other Comprehensive Income Loss Net Of Tax | -22256.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20250331 | Other Comprehensive Income Loss Net Of Tax | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | |||
| 0001641172-25-010547 | 20250331 | Prepaid Expense And Other Assets Current | 1101725.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20240331 | Shares Outstanding | 10758805.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-010547 | 20241231 | Shares Outstanding | 10784725.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-010547 | 20241231 | Shares Outstanding | shares | 0 | us-gaap/2024 | Equity Components= Preferred Stock; | |||
| 0001641172-25-010547 | 20241231 | Stockholders Equity | 1078.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-010547 | 20250331 | Stockholders Equity | -80562400.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001641172-25-010547 | 20250331 | Accounts Payable And Accrued Liabilities Current | 4124919.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 6377602.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20241231 | Commitments And Contingencies | USD | 0 | us-gaap/2024 | ||||
| 0001641172-25-010547 | 20250331 | Common Stock Value | 1078.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20240331 | Investment Income Net Amortization Of Discount And Premium | 34069.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20250331 | Liabilities And Stockholders Equity | 21096335.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20240331 | Net Income Loss | -5440810.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001641172-25-010547 | 20250331 | Net Income Loss | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | |||
| 0001641172-25-010547 | 20240331 | Operating Expenses | 5732001.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20250331 | Operating Income Loss | -4774032.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20240331 | Other Comprehensive Income Loss Net Of Tax | 109320.0000 | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001641172-25-010547 | 20241231 | Preferred Stock Shares Authorized | 1000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20241231 | Preferred Stock Shares Outstanding | 0.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20241231 | Prepaid Expense And Other Assets Current | 490000.0000 | USD | 0 | us-gaap/2024 | Type Of Arrangement= License Strategic Alliance And Research Agreements; | ||
| 0001641172-25-010547 | 20240331 | Proceeds From Warrant Exercises | 54716.0000 | USD | 1 | us-gaap/2024 | Equity Components= Warrant; | ||
| 0001641172-25-010547 | 20241231 | Retained Earnings Accumulated Deficit | -76025617.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010547 | 20240331 | Stockholders Equity | -60685214.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001641172-25-010547 | 20241231 | Stockholders Equity | 97058323.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-010547 | 20240331 | Stock Issued During Period Shares New Issues | 37613.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-010547 | 20240331 | Stock Issued During Period Value New Issues | 4.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| ddate | The end date for the data value, rounded to the nearest month end. |
| qtrs | The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value. |
| uom | The unit of measure for the value. |
| segments | Tags used to represent axis and member reporting. |
| coreg | If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity. |
| value | The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point. |
| footnote | The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank. |
| tag | version | custom | abstract | datatype | iord | crdr | tlabel | doc |
|---|---|---|---|---|---|---|---|---|
| Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets, Current | Amount of asset recognized for present right to economic benefit, classified as current. |
| Operating Lease Liability Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Operating Lease, Liability, Current | Present value of lessee's discounted obligation for lease payments from operating lease, classified as current. |
| Depreciation And Amortization | us-gaap/2024 | 0 | 0 | monetary | D | D | Depreciation, Depletion and Amortization, Nonproduction | The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production. |
| Payments To Acquire Property Plant And Equipment | us-gaap/2024 | 0 | 0 | monetary | D | C | Payments to Acquire Property, Plant, and Equipment | The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets. |
| Accounts Payable And Accrued Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Accounts Payable and Accrued Liabilities, Current | Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits. |
| Comprehensive Income Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. |
| Liabilities | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities | Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others. |
| Liabilities And Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities and Equity | Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. |
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax | Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale. |
| Other Noncash Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | Other Noncash Expense | Amount of expense or loss included in net income that result in no cash flow, classified as other. |
| Retained Earnings Accumulated Deficit | us-gaap/2024 | 0 | 0 | monetary | I | C | Retained Earnings (Accumulated Deficit) | Amount of accumulated undistributed earnings (deficit). |
| Additional Paid In Capital | us-gaap/2024 | 0 | 0 | monetary | I | C | Additional Paid in Capital | Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock. |
| Common Stock Par Or Stated Value Per Share | us-gaap/2024 | 0 | 0 | perShare | I | Common Stock, Par or Stated Value Per Share | Face amount or stated value per share of common stock. | |
| Common Stock Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Outstanding | Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. | |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2024 | 0 | 0 | monetary | D | D | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Equity Securities Fv Ni Realized Loss | us-gaap/2024 | 0 | 0 | monetary | D | D | Equity Securities, FV-NI, Realized Loss | Amount of realized loss from sale of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI). |
| Net Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Income (Loss) Attributable to Parent | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. |
| Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Equity, Attributable to Parent | Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest. |
| Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Diluted | The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. | |
| Accumulated Other Comprehensive Income Loss Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | I | C | Accumulated Other Comprehensive Income (Loss), Net of Tax | Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source. |
| Assets | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets | Amount of asset recognized for present right to economic benefit. |
| Common Stock Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Issued | Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. | |
| Earnings Per Share Diluted | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Diluted | The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. | |
| Prepaid Expense And Other Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Prepaid Expense and Other Assets, Current | Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer. |
| Operating Lease Right Of Use Asset | us-gaap/2024 | 0 | 0 | monetary | I | D | Operating Lease, Right-of-Use Asset | Amount of lessee's right to use underlying asset under operating lease. |
| Other Assets Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | D | Other Assets, Noncurrent | Amount of noncurrent assets classified as other. |
| Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities, Current | Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. |
| Marketable Securities Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Marketable Securities, Current | Amount of investment in marketable security, classified as current. |
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax | Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature. |
| Preferred Stock Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Issued | Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt. | |
| Proceeds From Sale And Maturity Of Marketable Securities | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Sale and Maturity of Marketable Securities | The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period. |
| Unrealized Gain Loss On Investments | us-gaap/2024 | 0 | 0 | monetary | D | C | Unrealized Gain (Loss) on Investments | Amount of unrealized gain (loss) on investment. |
| Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash and Cash Equivalents, at Carrying Value | Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. |
| Foreign Currency Transaction Gain Loss Before Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | Gain (Loss), Foreign Currency Transaction, before Tax | Amount, before tax, of realized and unrealized gain (loss) from foreign currency transaction. |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Prepaid Expense and Other Assets | Amount of increase (decrease) in prepaid expenses, and assets classified as other. |
| Other Comprehensive Income Loss Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | Other Comprehensive Income (Loss), Net of Tax | Amount after tax and reclassification adjustments of other comprehensive income (loss). |
| Preferred Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | C | Preferred Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | us-gaap/2024 | 0 | 0 | monetary | D | C | APIC, Share-Based Payment Arrangement, Option, Increase for Cost Recognition | Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement. |
| Debt Securities Available For Sale Realized Gain Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Debt Securities, Available-for-Sale, Realized Gain (Loss) | Amount of realized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). |
| Net Cash Provided By Used In Operating Activities | us-gaap/2024 | 0 | 0 | monetary | D | Net Cash Provided by (Used in) Operating Activities | Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. | |
| Operating Expenses | us-gaap/2024 | 0 | 0 | monetary | D | D | Operating Expenses | Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. |
| Operating Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Operating Income (Loss) | The net result for the period of deducting operating expenses from operating revenues. |
| Common Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | C | Common Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| General And Administrative Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | General and Administrative Expense | The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. |
| Investment Income Net Amortization Of Discount And Premium | us-gaap/2024 | 0 | 0 | monetary | D | C | Investment Income, Net, Amortization of Discount and Premium | Amount of accretion (amortization) of purchase discount (premium) on nonoperating securities. |
| Research And Development Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | Research and Development Expense | Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. |
| Stock Issued During Period Shares New Issues | us-gaap/2024 | 0 | 0 | shares | D | Stock Issued During Period, Shares, New Issues | Number of new stock issued during the period. | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2024 | 0 | 0 | monetary | D | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Commitments And Contingencies | us-gaap/2024 | 0 | 0 | monetary | I | C | Commitments and Contingencies | Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur. |
| Common Stock Shares Authorized | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares Authorized | The maximum number of common shares permitted to be issued by an entity's charter and bylaws. | |
| Employee Benefits And Share Based Compensation Noncash | us-gaap/2024 | 0 | 0 | monetary | D | D | Employee Benefit and Share-Based Payment Arrangement, Noncash | Amount of noncash expense (reversal of expense) for employee benefits and share-based payment arrangement. Includes, but is not limited to, pension, other postretirement, postemployment and termination benefits. |
| Increase Decrease In Operating Lease Liability | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Operating Lease Liability | Amount of increase (decrease) in obligation for operating lease. |
| Interest Income Other | us-gaap/2024 | 0 | 0 | monetary | D | C | Interest Income, Other | Amount of interest income earned from interest bearing assets classified as other. |
| Net Cash Provided By Used In Financing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Financing Activities | Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. |
| Preferred Stock Par Or Stated Value Per Share | us-gaap/2024 | 0 | 0 | perShare | I | Preferred Stock, Par or Stated Value Per Share | Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer. | |
| Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Shares, Outstanding | Number of shares issued which are neither cancelled nor held in the treasury. | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Earnings Per Share Basic | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Basic | The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. | |
| Increase Decrease In Accounts Payable And Accrued Liabilities | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accounts Payable and Accrued Liabilities | The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid. |
| Operating Lease Liability Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | C | Operating Lease, Liability, Noncurrent | Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent. |
| Net Cash Provided By Used In Investing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Investing Activities | Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. |
| Other Nonoperating Income Expense | us-gaap/2024 | 0 | 0 | monetary | D | C | Other Nonoperating Income (Expense) | Amount of income (expense) related to nonoperating activities, classified as other. |
| Payments To Acquire Marketable Securities | us-gaap/2024 | 0 | 0 | monetary | D | C | Payments to Acquire Marketable Securities | Amount of cash outflow for purchase of marketable security. |
| Preferred Stock Shares Authorized | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Authorized | The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws. | |
| Preferred Stock Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Outstanding | Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased. | |
| Stock Issued During Period Value New Issues | us-gaap/2024 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, New Issues | Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. |
| Proceeds From Warrant Exercises | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Warrant Exercises | The cash inflow associated with the amount received from holders exercising their stock warrants. |
| Property Plant And Equipment Net | us-gaap/2024 | 0 | 0 | monetary | I | D | Property, Plant and Equipment, Net | Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. |
| Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Basic | Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. |
| Field Name | Field Description |
|---|---|
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| custom | 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns. |
| abstract | 1 if the tag is not used to represent a numeric fact. |
| datatype | If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag. |
| iord | If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration. |
| crdr | If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL. |
| tlabel | If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here. |
| doc | The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL. |
| adsh | report | line | stmt | inpth | rfile | tag | version | plabel | negating |
|---|---|---|---|---|---|---|---|---|---|
| 0001641172-25-010547 | 5 | 6 | CI | 0 | H | Comprehensive Income Net Of Tax | us-gaap/2024 | Comprehensive loss | 0 |
| 0001641172-25-010547 | 2 | 2 | BS | 0 | H | Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | Cash and cash equivalents | 0 |
| 0001641172-25-010547 | 2 | 3 | BS | 0 | H | Marketable Securities Current | us-gaap/2024 | Marketable securities | 0 |
| 0001641172-25-010547 | 2 | 4 | BS | 0 | H | Prepaid Expense And Other Assets Current | us-gaap/2024 | Prepaid expenses & other current assets | 0 |
| 0001641172-25-010547 | 2 | 5 | BS | 0 | H | Assets Current | us-gaap/2024 | Total current assets | 0 |
| 0001641172-25-010547 | 2 | 6 | BS | 0 | H | Property Plant And Equipment Net | us-gaap/2024 | Property and equipment, net | 0 |
| 0001641172-25-010547 | 2 | 7 | BS | 0 | H | Operating Lease Right Of Use Asset | us-gaap/2024 | Operating lease right-of-use assets | 0 |
| 0001641172-25-010547 | 2 | 8 | BS | 0 | H | Other Assets Noncurrent | us-gaap/2024 | Other assets | 0 |
| 0001641172-25-010547 | 2 | 9 | BS | 0 | H | Assets | us-gaap/2024 | TOTAL ASSETS | 0 |
| 0001641172-25-010547 | 2 | 11 | BS | 0 | H | Accounts Payable And Accrued Liabilities Current | us-gaap/2024 | Accounts payable and accrued expenses | 0 |
| 0001641172-25-010547 | 2 | 12 | BS | 0 | H | Operating Lease Liability Current | us-gaap/2024 | Operating lease liabilities, current | 0 |
| 0001641172-25-010547 | 2 | 13 | BS | 0 | H | Liabilities Current | us-gaap/2024 | Total current liabilities | 0 |
| 0001641172-25-010547 | 2 | 14 | BS | 0 | H | Operating Lease Liability Noncurrent | us-gaap/2024 | Operating lease liabilities, net of current portion | 0 |
| 0001641172-25-010547 | 2 | 15 | BS | 0 | H | Liabilities | us-gaap/2024 | TOTAL LIABILITIES | 0 |
| 0001641172-25-010547 | 2 | 16 | BS | 0 | H | Commitments And Contingencies | us-gaap/2024 | COMMITMENTS AND CONTINGENCIES (NOTE 4) | 0 |
| 0001641172-25-010547 | 2 | 18 | BS | 0 | H | Preferred Stock Value | us-gaap/2024 | Preferred Stock (1,000,000 authorized at March 31, 2025 and December 31, 2024; $.0001 par value) (Zero shares issued and outstanding at March 31, 2025 and December 31, 2024) | 0 |
| 0001641172-25-010547 | 2 | 19 | BS | 0 | H | Common Stock Value | us-gaap/2024 | Common Stock (25,000,000 authorized at March 31, 2025 and December 31, 2024; $.0001 par value) (10,784,725 shares issued and outstanding at March 31, 2025 and December 31, 2024) | 0 |
| 0001641172-25-010547 | 2 | 20 | BS | 0 | H | Additional Paid In Capital | us-gaap/2024 | Additional paid-in capital | 0 |
| 0001641172-25-010547 | 2 | 21 | BS | 0 | H | Accumulated Other Comprehensive Income Loss Net Of Tax | us-gaap/2024 | Accumulated other comprehensive income | 0 |
| 0001641172-25-010547 | 2 | 22 | BS | 0 | H | Retained Earnings Accumulated Deficit | us-gaap/2024 | Accumulated deficit | 0 |
| 0001641172-25-010547 | 2 | 23 | BS | 0 | H | Stockholders Equity | us-gaap/2024 | Total stockholders equity | 0 |
| 0001641172-25-010547 | 2 | 24 | BS | 0 | H | Liabilities And Stockholders Equity | us-gaap/2024 | TOTAL LIABILITIES AND STOCKHOLDERS EQUITY | 0 |
| 0001641172-25-010547 | 3 | 1 | BS | 1 | H | Preferred Stock Shares Authorized | us-gaap/2024 | Preferred stock, shares authorized | 0 |
| 0001641172-25-010547 | 3 | 2 | BS | 1 | H | Preferred Stock Par Or Stated Value Per Share | us-gaap/2024 | Preferred stock, par value | 0 |
| 0001641172-25-010547 | 3 | 3 | BS | 1 | H | Preferred Stock Shares Issued | us-gaap/2024 | Preferred stock, shares issued | 0 |
| 0001641172-25-010547 | 3 | 4 | BS | 1 | H | Preferred Stock Shares Outstanding | us-gaap/2024 | Preferred stock, shares outstanding | 0 |
| 0001641172-25-010547 | 3 | 5 | BS | 1 | H | Common Stock Shares Authorized | us-gaap/2024 | Common stock, shares authorized | 0 |
| 0001641172-25-010547 | 3 | 6 | BS | 1 | H | Common Stock Par Or Stated Value Per Share | us-gaap/2024 | Common stock, par value | 0 |
| 0001641172-25-010547 | 3 | 7 | BS | 1 | H | Common Stock Shares Issued | us-gaap/2024 | Common stock, shares issued | 0 |
| 0001641172-25-010547 | 3 | 8 | BS | 1 | H | Common Stock Shares Outstanding | us-gaap/2024 | Common stock, shares outstanding | 0 |
| 0001641172-25-010547 | 4 | 2 | IS | 0 | H | General And Administrative Expense | us-gaap/2024 | General and administrative | 0 |
| 0001641172-25-010547 | 4 | 3 | IS | 0 | H | Research And Development Expense | us-gaap/2024 | Research and development | 0 |
| 0001641172-25-010547 | 4 | 4 | IS | 0 | H | Operating Expenses | us-gaap/2024 | Total operating expenses | 0 |
| 0001641172-25-010547 | 4 | 5 | IS | 0 | H | Operating Income Loss | us-gaap/2024 | Loss from operations | 0 |
| 0001641172-25-010547 | 4 | 6 | IS | 0 | H | Interest Income Other | us-gaap/2024 | Interest income | 0 |
| 0001641172-25-010547 | 4 | 7 | IS | 0 | H | Other Nonoperating Income Expense | us-gaap/2024 | Other income, net | 0 |
| 0001641172-25-010547 | 4 | 8 | IS | 0 | H | Net Income Loss | us-gaap/2024 | NET LOSS | 0 |
| 0001641172-25-010547 | 4 | 9 | IS | 0 | H | Earnings Per Share Basic | us-gaap/2024 | Net loss per share of common shares, basic | 0 |
| 0001641172-25-010547 | 4 | 10 | IS | 0 | H | Earnings Per Share Diluted | us-gaap/2024 | Net loss per share of common shares, diluted | 0 |
| 0001641172-25-010547 | 4 | 11 | IS | 0 | H | Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | Weighted-average number of common shares outstanding, basic | 0 |
| 0001641172-25-010547 | 4 | 12 | IS | 0 | H | Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | Weighted-average number of common shares outstanding, diluted | 0 |
| 0001641172-25-010547 | 5 | 1 | CI | 0 | H | Net Income Loss | us-gaap/2024 | NET LOSS | 0 |
| 0001641172-25-010547 | 5 | 3 | CI | 0 | H | Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | us-gaap/2024 | Unrealized (loss) gain on available-for-sale securities | 0 |
| 0001641172-25-010547 | 5 | 4 | CI | 0 | H | Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | us-gaap/2024 | Unrealized (loss) gain on foreign currency translation | 0 |
| 0001641172-25-010547 | 5 | 5 | CI | 0 | H | Other Comprehensive Income Loss Net Of Tax | us-gaap/2024 | Other comprehensive (loss) income | 0 |
| 0001641172-25-010547 | 6 | 10 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Balance | 0 |
| 0001641172-25-010547 | 6 | 11 | EQ | 0 | H | Shares Outstanding | us-gaap/2024 | Balance, shares | 0 |
| 0001641172-25-010547 | 6 | 12 | EQ | 0 | H | Stock Issued During Period Value New Issues | us-gaap/2024 | Common stock issued from warrant exercises | 0 |
| 0001641172-25-010547 | 6 | 13 | EQ | 0 | H | Stock Issued During Period Shares New Issues | us-gaap/2024 | Common stock issued from warrant exercises, shares | 0 |
| 0001641172-25-010547 | 6 | 14 | EQ | 0 | H | Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | us-gaap/2024 | Stock-based compensation | 0 |
| 0001641172-25-010547 | 6 | 15 | EQ | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
| 0001641172-25-010547 | 6 | 16 | EQ | 0 | H | Other Comprehensive Income Loss Net Of Tax | us-gaap/2024 | Other comprehensive income (loss) | 0 |
| 0001641172-25-010547 | 6 | 17 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Balance | 0 |
| 0001641172-25-010547 | 6 | 18 | EQ | 0 | H | Shares Outstanding | us-gaap/2024 | Balance, shares | 0 |
| 0001641172-25-010547 | 7 | 2 | CF | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
| 0001641172-25-010547 | 7 | 4 | CF | 0 | H | Depreciation And Amortization | us-gaap/2024 | Depreciation and amortization | 0 |
| 0001641172-25-010547 | 7 | 5 | CF | 0 | H | Other Noncash Expense | us-gaap/2024 | Non-cash lease adjustments | 0 |
| 0001641172-25-010547 | 7 | 6 | CF | 0 | H | Employee Benefits And Share Based Compensation Noncash | us-gaap/2024 | Stock-based compensation | 0 |
| 0001641172-25-010547 | 7 | 7 | CF | 0 | H | Investment Income Net Amortization Of Discount And Premium | us-gaap/2024 | Accretion of discounts on available for sale debt securities, net | 1 |
| 0001641172-25-010547 | 7 | 8 | CF | 0 | H | Foreign Currency Transaction Gain Loss Before Tax | us-gaap/2024 | Foreign currency remeasurement (gain) loss | 1 |
| 0001641172-25-010547 | 7 | 9 | CF | 0 | H | Debt Securities Available For Sale Realized Gain Loss | us-gaap/2024 | Realized (gain) loss on redemptions of available for sale debt securities | 1 |
| 0001641172-25-010547 | 7 | 10 | CF | 0 | H | Equity Securities Fv Ni Realized Loss | us-gaap/2024 | Realized loss on redemption of equity securities | 0 |
| 0001641172-25-010547 | 7 | 11 | CF | 0 | H | Unrealized Gain Loss On Investments | us-gaap/2024 | Unrealized gain on equity securities | 1 |
| 0001641172-25-010547 | 7 | 13 | CF | 0 | H | Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2024 | Prepaid expenses and other current assets | 1 |
| 0001641172-25-010547 | 7 | 14 | CF | 0 | H | Increase Decrease In Accounts Payable And Accrued Liabilities | us-gaap/2024 | Accounts payable and accrued expenses | 0 |
| 0001641172-25-010547 | 7 | 15 | CF | 0 | H | Increase Decrease In Operating Lease Liability | us-gaap/2024 | Operating lease liabilities | 0 |
| 0001641172-25-010547 | 7 | 16 | CF | 0 | H | Net Cash Provided By Used In Operating Activities | us-gaap/2024 | Net cash flows used in operating activities | 0 |
| 0001641172-25-010547 | 7 | 18 | CF | 0 | H | Payments To Acquire Property Plant And Equipment | us-gaap/2024 | Purchase of property and equipment | 1 |
| 0001641172-25-010547 | 7 | 19 | CF | 0 | H | Payments To Acquire Marketable Securities | us-gaap/2024 | Purchases of marketable securities | 1 |
| 0001641172-25-010547 | 7 | 20 | CF | 0 | H | Proceeds From Sale And Maturity Of Marketable Securities | us-gaap/2024 | Redemptions of marketable securities | 0 |
| 0001641172-25-010547 | 7 | 21 | CF | 0 | H | Net Cash Provided By Used In Investing Activities | us-gaap/2024 | Net cash flows provided by (used in) investing activities | 0 |
| 0001641172-25-010547 | 7 | 23 | CF | 0 | H | Proceeds From Warrant Exercises | us-gaap/2024 | Proceeds from warrant exercises | 0 |
| 0001641172-25-010547 | 7 | 24 | CF | 0 | H | Net Cash Provided By Used In Financing Activities | us-gaap/2024 | Net cash flows provided by financing activities | 0 |
| 0001641172-25-010547 | 7 | 25 | CF | 0 | H | Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2024 | Effect of foreign exchange rates on cash | 0 |
| 0001641172-25-010547 | 7 | 26 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2024 | CHANGE IN CASH AND CASH EQUIVALENTS FOR THE PERIOD | 0 |
| 0001641172-25-010547 | 7 | 27 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2024 | CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD | 0 |
| 0001641172-25-010547 | 7 | 28 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2024 | CASH AND CASH EQUIVALENTS, END OF PERIOD | 0 |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| report | Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site. |
| line | Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived. |
| stmt | The financial statement location to which the value of the “report” field pertains. |
| inpth | Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700. |
| rfile | The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file. |
| tag | The tag chosen by the filer for this line item. |
| version | The taxonomy identifier if the tag is a standard tag, otherwise adsh. |
| plabel | The text presented on the line item, also known as a “preferred” label. |
| negating | Flag to indicate whether the plabel is negating. |